98 related articles for article (PubMed ID: 21395548)
1. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
[TBL] [Abstract][Full Text] [Related]
2. Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.
Connolly EC; Saunier EF; Quigley D; Luu MT; De Sapio A; Hann B; Yingling JM; Akhurst RJ
Cancer Res; 2011 Mar; 71(6):2339-49. PubMed ID: 21282335
[TBL] [Abstract][Full Text] [Related]
3. MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells.
Djediai S; Gonzalez Suarez N; El Cheikh-Hussein L; Rodriguez Torres S; Gresseau L; Dhayne S; Joly-Lopez Z; Annabi B
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884812
[TBL] [Abstract][Full Text] [Related]
4. Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.
Radaev S; Zou Z; Huang T; Lafer EM; Hinck AP; Sun PD
J Biol Chem; 2010 May; 285(19):14806-14. PubMed ID: 20207738
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks.
Tokizaki S; Podyma-Inoue KA; Matsumoto T; Takahashi K; Kobayashi M; Ibi H; Uchida S; Iwabuchi S; Harada H; Hashimoto S; Miyazono K; Shirouzu M; Watabe T
Cancer Sci; 2024 Jan; 115(1):211-226. PubMed ID: 37972575
[TBL] [Abstract][Full Text] [Related]
6. A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.
Wu Y; Tran T; Dwabe S; Sarkissyan M; Kim J; Nava M; Clayton S; Pietras R; Farias-Eisner R; Vadgama JV
Breast Cancer Res Treat; 2017 Jun; 163(3):449-460. PubMed ID: 28337662
[TBL] [Abstract][Full Text] [Related]
7. The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.
Qi Y; Wang CC; He YL; Zou H; Liu CX; Pang LJ; Hu JM; Jiang JF; Zhang WJ; Li F
Int J Clin Exp Pathol; 2013; 6(12):2787-99. PubMed ID: 24294365
[TBL] [Abstract][Full Text] [Related]
8. Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway.
Herbertz S; Sawyer JS; Stauber AJ; Gueorguieva I; Driscoll KE; Estrem ST; Cleverly AL; Desaiah D; Guba SC; Benhadji KA; Slapak CA; Lahn MM
Drug Des Devel Ther; 2015; 9():4479-99. PubMed ID: 26309397
[TBL] [Abstract][Full Text] [Related]
9. Suppression of injury-induced epithelial-mesenchymal transition in a mouse lens epithelium lacking tenascin-C.
Tanaka S; Sumioka T; Fujita N; Kitano A; Okada Y; Yamanaka O; Flanders KC; Miyajima M; Saika S
Mol Vis; 2010 Jul; 16():1194-205. PubMed ID: 20664686
[TBL] [Abstract][Full Text] [Related]
10. An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype.
Larocca C; Cohen JR; Fernando RI; Huang B; Hamilton DH; Palena C
Mol Cancer Ther; 2013 Sep; 12(9):1805-15. PubMed ID: 23783250
[TBL] [Abstract][Full Text] [Related]
11. Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan.
Madamanchi A; Ingle M; Hinck AP; Umulis DM
Biophys J; 2023 Apr; 122(7):1342-1354. PubMed ID: 36869592
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of a pyrazolo[3,4-d]pyrimidine derivative as a novel and potent TGFβ1R1 inhibitor.
Wang Y; Liu Y; Zhang Y; Zhang Z; Xu L; Wang J; Yang Y; Hu B; Yao Y; Wei M; Wang J; Tang B; Zhang K; Liu S; Yang G
Eur J Med Chem; 2024 May; 271():116395. PubMed ID: 38626523
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.
Ghosh AK; Nagpal V; Covington JW; Michaels MA; Vaughan DE
Cell Signal; 2012 May; 24(5):1031-6. PubMed ID: 22245495
[TBL] [Abstract][Full Text] [Related]
14. The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor.
Jin W; Kim BC; Tognon C; Lee HJ; Patel S; Lannon CL; Maris JM; Triche TJ; Sorensen PH; Kim SJ
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16239-44. PubMed ID: 16258068
[TBL] [Abstract][Full Text] [Related]
15. IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver.
Liu C; Billadeau DD; Abdelhakim H; Leof E; Kaibuchi K; Bernabeu C; Bloom GS; Yang L; Boardman L; Shah VH; Kang N
J Clin Invest; 2013 Mar; 123(3):1138-56. PubMed ID: 23454766
[TBL] [Abstract][Full Text] [Related]
16. Riboflavin protects against pancreatic cancer metastasis by targeting TGF-β receptor 1.
Zhao J; Liu X; Jin X; Dong T; Gao X; Wang J; Li Y; Ma E
Bioorg Chem; 2024 May; 146():107274. PubMed ID: 38503026
[TBL] [Abstract][Full Text] [Related]
17. Prodigiosin Inhibits Transforming Growth Factor
Tai SB; Huang CY; Chung CL; Sung PJ; Wen ZH; Chen CL
Mol Pharmacol; 2024 Mar; 105(4):286-300. PubMed ID: 38278554
[TBL] [Abstract][Full Text] [Related]
18. Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway.
Carl C; Flindt A; Hartmann J; Dahlke M; Rades D; Dunst J; Lehnert H; Gieseler F; Ungefroren H
Cell Mol Life Sci; 2016 Jan; 73(2):427-43. PubMed ID: 26238393
[TBL] [Abstract][Full Text] [Related]
19. Jagged-1 is induced by mTOR inhibitors in renal cancer cells through an Akt/ALK5/Smad4-dependent mechanism.
Danielpour D; Corum S; Leahy P; Bangalore A
Curr Res Pharmacol Drug Discov; 2022; 3():100117. PubMed ID: 35992379
[TBL] [Abstract][Full Text] [Related]
20. The TβR-I pre-helix extension is structurally ordered in the unbound form and its flanking prolines are essential for binding.
Zuniga JE; Ilangovan U; Mahlawat P; Hinck CS; Huang T; Groppe JC; McEwen DG; Hinck AP
J Mol Biol; 2011 Sep; 412(4):601-18. PubMed ID: 21821041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
